//
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators
Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial